Home » Topics » Regulatory » Patents

Patents
RSS

Beijing Findcure Biosciences divulges new tyrosine-protein kinase receptor UFO inhibitors

Feb. 2, 2022

Sichuan Haisco Pharmaceutical discovers polymerase basic protein 2 inhibitors

Feb. 2, 2022

PI3K-delta inhibitors patented by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

Feb. 2, 2022

New DDR1 and/or DDR2 inhibitors identified at Galapagos

Feb. 2, 2022

Science & Technology Development Fund Authority presents new antiviral nucleosides

Feb. 2, 2022

Vitalixir presents new antidiabetic polypeptides

Feb. 1, 2022

Shenzhen Salubris Pharmaceuticals patents ADAM-TS 5 inhibitors

Feb. 1, 2022

Abbisko Therapeutics discovers EGFR inhibtors

Feb. 1, 2022

New PROTACs targeting androgen receptors sythesized at Sichuan Haisco Pharmaceutical

Feb. 1, 2022

New ENPP2 inhibitors identified at Suzhou Ark Biopharmaceutical

Feb. 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...